Global Transdermal Drug Delivery System (TDDS) Markets to 2023: Leading Players are 3M, Zosano Pharma Corporation, Tesa Labtec and Tapemark - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transdermal Drug Delivery System Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.

The global transdermal drug delivery system market is estimated to register a CAGR of 8.91% over the forecast period of 2017-2023.

The rise in the market is attributed to the rising adoption of the TDDS due to the various advantages offered by TDDS such as prolonged therapeutic effect, reduced side-effects, improved bioavailability, better patient compliance and easy termination of drug therapy. However, inability of the skin to absorb large range of medications will restrain the market during the forecast period.

Major industry players profiled as part of the report are 3M, Zosano Pharma Corporation, Tesa Labtec GmbH and Tapemark among others.

Segmentation

By Type

• Patches
• Gels and Ointments

By Application

• Neurologic Conditions
• Pain Management
• Nicotine Cessation
• Cardiovascular
• Others

By End-User

• Hospitals and Clinics
• Surgical Centers
• Home Care Settings

By Geography

• North America
• South America
• Europe
• Middle East and Africa
• Asia Pacific

Key Topics Covered

1. Introduction

2. Research Methodology

3. Key Findings of the Study

4. Market Dynamics

5. Global Transdermal Drug Delivery System Market Forecast by Type

6. Global Transdermal Drug Delivery System Market Forecast by Application

7. Global Transdermal Drug Delivery System Market Forecast by Application

8. Global Transdermal Drug Delivery System Market Forecast by Geography

9. Competitive intelligence

10. Company Profiles

• 3M
• ProSolus, Inc.
• Zosano Pharma Corporation
• MedPharm
• Tesa Labtec GmbH
• Medherant Limited
• Tapemark
• Toyochem Co. Ltd.
• Delivra Corp
• Epinamics GmbH

For more information about this report visit https://www.researchandmarkets.com/research/n3cj4p/global?w=4